Preferred Dental Technologies Inc. Receives Notice of Additional Patent to be Granted for the EU Countries

PDTI Preferred Dental Technologies Inc. CSE:PDTI Technology, Medical Device, 牙科,科技,医疗设备
Published on: Apr 17, 2018

Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI, US OTC: PDTTF) has received correspondence from our patent agent that the European Patent Office has stated its intent to grant an additional patent for the EAS Series.

As the core technology of the EAS Series has tremendous potential for adaptation in terms of material, design, processes and applications, continued Research & Development has been an integral part of the company’s activities. The need to protect these additional developments is vital as these new designs establishes new verticals for additional markets and growth potential.

Preferred Dental Technologies is committed to the concept of “Value Plus” by delivering a superior product at the same or lessor price than competitive products that cannot match the versatility of the EAS Series. The majority of small companies in this space rely on providing older cloned technology and do not possess their own unique Intellectual Property. Preferred Dental is in a rare position for a company our size by developing, owning and offering new, patented Intellectual Property.

Mr. Erik Siegmund, President, stated, “We are committed to continued development of the EAS Series. With the core technology being well reviewed, we have always known that the unique design has the potential to reach far beyond its initial patents. From digital dental offerings to non-precious material developments, each additional patent represents new increased IT value in the company’s product portfolio and expands our reach into additional markets. I am very pleased to see this advancement with the European Patent Office on this matter as it provides protection and stability in the quality and innovation driven EU markets.”

About PDTI

Preferred Dental technologies Inc. (PDTI) has been established to advance development and commercialization of various evolutionary and disruptive technologies in the dental implant industry.

MISSION – INNOVATIVE & PRACTICAL SOLUTIONS FOR THE DENTAL INDUSTRY

Visit: www.preferreddentalimplant.com www.prefdent.com

On behalf of Preferred Dental Technologies Inc.

Erik Siegmund

Chief Executive Officer

Email: [email protected]

Tel: 204.691.3722

www.prefdent.com

 This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the Company’s objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company’s public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither The Canadian Securities Exchange nor its Regulations Services Provider (as that term is defined in the policies of The Canadian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.

Medical Device Technology